Cullinan Therapeutics CGEM
NASDAQ CGEM
$11.35 +0.12 (+1.07%)
At close: Nov 11, 2026 · 4:00 PM EST

Cullinan Therapeutics (CGEM) Return on Equity [ROE] (2020 - 2026)

Updated

Cullinan Therapeutics' Return on Equity [ROE] came in at -59.51% for Q2 2026, down 19.90 percentage points from -39.61% a year earlier and down 2.46 percentage points from the prior quarter.

Analysis

Cullinan Therapeutics (CGEM) Return on Equity [ROE] (2020 - 2026) Analysis & Trends

For FY2025, Cullinan Therapeutics' Return on Equity [ROE] was -44.02%, down 11.92 percentage points from FY2024.

  • Return on Equity [ROE] has declined in each of the last three years, with a four-year change of -22.45 percentage points (FY2021 to FY2025).
  • Going back by year, Return on Equity [ROE] was -32.10% in FY2024 (-0.73 pp), -31.37% in FY2023 (-54.11 pp), 22.74% in FY2022 (+44.31 pp) and -21.57% in FY2021.
  • The Q2 2026 figure represents the lowest quarterly Return on Equity [ROE] in data going back to Q4 2020.
  • Year-over-year, Return on Equity [ROE] has declined for six consecutive quarters, with an average year-over-year change of -11.31 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Equity [ROE] over five years came in Q4 2022 (a gain of 34.98 percentage points), and the weakest in Q4 2023 (a drop of 53.10 percentage points).
  • Business Quant data shows CGEM's Return on Equity [ROE] at -57.05% (Q1 2026), -51.13% (Q4 2025) and -45.96% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Cullinan Therapeutics 722.60 Mn -1.13 Bn - -67.48%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -67.48%
Jun 30, 2026 -59.51%
Mar 31, 2026 -57.05%
Dec 31, 2025 -51.13%
Sep 30, 2025 -45.96%
Jun 30, 2025 -39.61%
Mar 31, 2025 -31.30%
Dec 31, 2024 -27.51%
Sep 30, 2024 -22.66%
Jun 30, 2024 -26.64%
Mar 31, 2024 -30.54%
Dec 31, 2023 -33.62%
Sep 30, 2023 -32.35%
Jun 30, 2023 -28.89%
Mar 31, 2023 12.53%
Dec 31, 2022 19.48%
Sep 30, 2022 17.15%
Jun 30, 2022 21.23%
Mar 31, 2022 -19.36%
Dec 31, 2021 -15.50%
API Access

Cullinan Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CGEM&period=max&api_key=YOUR_API_KEY